Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

AADAC anticorps

AADAC Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN2422361
  • Antigène Voir toutes AADAC Anticorps
    AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
    Reactivité
    • 26
    • 18
    • 17
    • 4
    • 2
    • 2
    • 2
    • 1
    Humain
    Hôte
    • 39
    • 2
    Lapin
    Clonalité
    • 40
    • 1
    Polyclonal
    Conjugué
    • 17
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp AADAC est non-conjugé
    Application
    • 29
    • 13
    • 13
    • 12
    • 5
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Purification
    Affinity purification
    Immunogène
    Recombinant protein of human AADAC
    Isotype
    IgG
    Top Product
    Discover our top product AADAC Anticorps primaire
  • Indications d'application
    WB 1:500-1:2000, IHC 1:50-1:100
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.2 mg/mL
    Buffer
    PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
    Agent conservateur
    Sodium azide
    Conseil sur la manipulation
    Avoid freeze / thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène
    AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
    Autre désignation
    AADAC (AADAC Produits)
    Synonymes
    anticorps MGC89272, anticorps AADAC, anticorps CES5A1, anticorps DAC, anticorps Aada, anticorps 5033417E09Rik, anticorps AI265437, anticorps arylacetamide deacetylase, anticorps arylacetamide deacetylase S homeolog, anticorps Arylacetamide deacetylase, anticorps arylacetamide deacetylase (esterase), anticorps LOC100056411, anticorps aadac, anticorps AADAC, anticorps aadac.S, anticorps LOC100451808, anticorps ACD3, anticorps PTRG_10278, anticorps aaad, anticorps Aadac
    Sujet
    Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens. Arylacetamide deacetylation is an important enzyme activity in the metabolic activation of arylamine substrates to ultimate carcinogens. Displays major serine hydrolase activity in liver microsomes. Hydrolyzes also flutamide, which is an antiandrogen drug used for the treatment of prostate cancer that occasionally causes severe hepatotoxicity. Displays cellular triglyceride lipase activity in liver. Increases intracellular fatty acids derived from hydrolysis of newly formed triglyceride stores.
    Poids moléculaire
    Calculated MW: 46 kDa
Vous êtes ici:
Support technique